Nimbus Therapeutics - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $85,955.09 -2.07%
Ethereum $2,819.12 -4.50%
BNB $838.32 -3.88%
Optimism $0.27 -7.60%
Arbitrum $0.18 -8.60%
Solana $122.36 -4.77%
Polygon $0.22 +2.77%
Cosmos $1.94 -4.10%
Avalanche $11.83 -4.10%

Bitcoin $85,955.09 -2.07%
Ethereum $2,819.12 -4.50%
BNB $838.32 -3.88%
Optimism $0.27 -7.60%
Arbitrum $0.18 -8.60%
Solana $122.36 -4.77%
Polygon $0.22 +2.77%
Cosmos $1.94 -4.10%
Avalanche $11.83 -4.10%

Nimbus Therapeutics

company

Investors

Number of Lead Investors

Number of Investors

7

17

Nimbus Therapeutics is funded by 17 investors. Access Biotechnology and Atlas Venture are the most recent investors.

Investor Name	Lead Investor	Funding Round
Access Biotechnology	-	Series Unknown
Atlas Venture	-	Series Unknown
Bain Capital Life Sciences	-	Series Unknown
Bill Gates	-	Series Unknown
Biotechnology Value Fund	-	Series Unknown
Lightstone Ventures	-	Series Unknown
Pfizer Venture Investments	-	Series Unknown
RA Capital Management	-	Series Unknown
SR One	-	Series Unknown
SV Health Investors	-	Series Unknown
Commodore Capital	-	Series Unknown
Logos Capital	-	Series Unknown
Surveyor Capital	-	Series Unknown
BVF Partners	-	Series Unknown
Lilly Ventures	-	Series C
Schrödinger	-	Series C
Richard Friesner	-	Seed